Osteonectin is a bone-associated protein involved in vascular calcification. Adiponectin may protect against cardiovascular disease but possible effects on vascular calcification have been poorly studied. The aim of this study was to investigate the modulatory effect of adiponectin on oxidized low density lipoprotein (oxLDL)-induced expression of osteonectin in human aorta vascular smooth muscle cells (HA/VSMCs). HA/VSMCs were cultured in F12K media and then treated with oxLDL (100 µg/mL) in the presence or absence of adoponectin (5 µg/mL) for 24 and 48 hours. mRNA expression and protein level of osteonectin were determined by quantitative real-time PCR and western blot analysis, respectively. After exposure to oxLDL, osteonectin expression increased 1.62 ± 0.23-and 6.62 ± 0.48-fold after 24 and 48 hours respectively compared to the control.
therosclerosis is a disorder characterized by the presence of atherosclerotic plaques in the arterial intima that leads to luminal narrowing (1, 2) . Calcification is a common event that occurs in the early phase of arteriosclerosis (3, 4) which is predisposing to coronary artery damage after angioplasty (5) . Calcification reduces the blood walls elasticity that can lead to other cardiovascular problems (6) . Oxidized low density lipoprotein (OxLDL) has been postulated to play an important role in foam cells formation and its accumulation in the vascular wall which stimulates the development of atherosclerosis and vascular calcification (7) .
Osteonectin, also known as secreted protein acidic and rich in cysteine (SPARC) is an extracellular matrix protein expressed in active remodeling in the skeleton and other tissues (8) .
A Submmited 23 September 2014 ; Accepted 3 January 2015; Published 13 February 2015 As with other bone-related proteins, osteonectin is expressed in the arterial wall during atherosclerosis progress specifically during calcification of the atherosclerotic plaque (9) (10) (11) .
Adiponectin is one of the adipocytokines released only from adipose tissue, which protects from the development and progression of atherosclerosis via anti-inflammatory effects. Decreased plasma adiponectin concentrations were reported in patients with coronary artery disease (12) . Experimental studies have shown that adiponectin has potential antiatherogenic characteristics (12, 13) .
Several experimental findings suggest that adiponectin may protect against cardiovascular inflammation (14, 15) , but the possible effects of adiponectin on vascular calcification have not been fully investigated. Adiponectin probably reduces calcification process and therefore can be effective on reducing the risk of atherosclerosis (16) (17) (18) (19) . The aim of the present study was to investigate the effect of adiponectin on osteonectin expression in vascular smooth muscle cells (VSMCs) treated with oxLDL.
Materials and methods

Cell culture
In this experimental study, human aorta 
RNA isolation and cDNA synthesis
Total RNA was extracted from the cells using 
Real-time polymerase chain reaction (PCR)
Real-time PCR was performed using Rotor- Quantitation of data was performed using the comparative C T (∆∆C T ) method, using glyceraldehyde 3-phosphate dehydrogenase gene expression as an endogenous reference.
Western blot
Cells were washed twice with cold phosphate buffered saline (PBS) and were lysed in ice-cold 2X radio-immune precipitation assay (RIPA) buffer.
The homogenate was incubated in lysis buffer for 
Statistical analyzes
All experiments were done in triplicate. Statistical analyzes were done using nonparametric Kruskal-Wallis test. Pairwise comparisons between groups were performed by Mann-Whitney test. All statistical analyzes were performed with Graph Pad Prism5 software. All data were presented as mean±SEM and P <0.05 was considered as the level of significance.
Results
First, we examined the effect of oxLDL on osteonectin gene expression in VSMCs. Our results showed that oxLDL increased osteonectin expression 1.62 ± 0.23-and 6.62 ± 0.48-fold after 24 and 48 hours, respectively compared with the control group (P=0.01) (Figures 1A, 2A) . Then, we examined the effect of adiponectin on osteonectin expression in oxLDL-induced VSMCs. Interestin-gly, when VSMCs were treated with both oxLDL and adiponectin there was an additional effect on osteonectin expression (3.24 ± 0.39-and 24.93 ± 2.15-fold after 24 and 48 hours, respectively) (P=0.001) (Figures 1A, 2A) .
The results were confirmed by western blot analysis at protein levels. oxLDL alone and together with adiponectin increased the osteonectin protein level (Figures 1B, 2B ). Beta actin (42 kDa) was used as an internal control to standardize the protein loading in western blotting experiments.
Discussion
Blood osteonectin concentration correlated significantly with atherosclerosis, stenosis and calcinosis of coronary arteries (20) . In the present study, oxLDL increased osteonectin expression in There are few reports on the preservative effects of adiponectin in arterial wall calcification (24, 25) but the adverse effects of adiponectin have been reported (26, 27) . In a study, the relationship between adiponectin and coronary heart disease in old adults was investigated and the direct correlation between high adiponectin and the risk of coronary heart disease was reported (28).
Our results showed that adiponectin intensi- 
